tiprankstipranks

DAVID EDWARD JOHNSON Insider Profile

4 Followers
DAVID EDWARD JOHNSON, Director, Ten Percent Owner at Amag Pharmaceuticals, holds 0.00 shares in Amag Pharmaceuticals (Ticker: AMAG), holds ― shares in Liquidia Technologies (Ticker: LQDA), holds 1.12M shares in Exelixis (Ticker: EXEL).
tipranks
DAVID EDWARD JOHNSON

DAVID EDWARD JOHNSON
Amag Pharmaceuticals (AMAG)
Director, Ten Percent Owner

Ranked #44,170 out of 98,743 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+2.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$24M
100.00%
0.00%
A breakdown of DAVID EDWARD JOHNSON's holdings

Insider Roles

Exelixis
(EXEL)
Director
Liquidia Technologies
(LQDA)
Director, See Remarks, Ten Percent Owner
Roles that DAVID EDWARD JOHNSON holds in companies

Most Profitable Insider Trade

Stock:
Exelixis
(EXEL)
Rating:Informative Buy
Date:Feb 22, 2024 - Today
Return:+5.70%
The most profitable trade made by DAVID EDWARD JOHNSON

DAVID EDWARD JOHNSON's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AMAG
Amag Pharmaceuticals
Nov 17, 2020
Uninformative Sell
$0.00
Liquidia Technologies
Director, See Remarks, Ten Percent Owner
Exelixis
Feb 22, 2024
Director
Informative Buy
3.93M
$24.35M
List of latest transactions for each holding click on a transaction to see DAVID EDWARD JOHNSON's performance on stock

DAVID EDWARD JOHNSON insider profile FAQ

What is the percentage of profitable transactions made by DAVID EDWARD JOHNSON?
The percentage of profitable transactions made by DAVID EDWARD JOHNSON is 67%.
    What is the average return per transaction made by DAVID EDWARD JOHNSON?
    The average return per transaction made by DAVID EDWARD JOHNSON is 2.70%.
      What stocks does DAVID EDWARD JOHNSON hold?
      DAVID EDWARD JOHNSON holds: AMAG, LQDA, EXEL stocks.
        What was DAVID EDWARD JOHNSON’s latest transaction?
        DAVID EDWARD JOHNSON latest transaction was an Uninformative Sell of ―.
          What was DAVID EDWARD JOHNSON's most profitable transaction?
          DAVID EDWARD JOHNSON’s most profitable transaction was an Informative Buy of EXEL stock on February 22, 2024. The return on the trade was 5.70%.
            What is DAVID EDWARD JOHNSON's role in Amag Pharmaceuticals?
            DAVID EDWARD JOHNSON's role in Amag Pharmaceuticals is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.